English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe findings of the study by the Rutgers Institute for Health, Health Care Policy and Aging Research underscore the need for culturally targeted interventions to prevent and reduce tobacco use, manage chronic disease and screen for lung cancer.
Tag: Lung Cancer
Lung Cancer Program at NYU Langone Health’s Perlmutter Cancer Center Joins Prestigious Thoracic Surgery Oncology Group
NYU Langone Health has become one of 23 institutions selected to comprise the American Association for Thoracic Surgery’s Thoracic Surgery Oncology Group (TSOG). A North American thoracic surgery clinical trials network, TSOG aims to improve the understanding of thoracic oncologic diseases and enhance the care of patients.
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer. Pegilodecakin with pembrolizumab and nivolumab shown to be safe in Phase IB study
Yale Cancer Center researchers show adding radiation after immunotherapy improves survival time for patients with advanced lung cancer
The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).
Yale Cancer Center researchers show adding radiation after immunotherapy improves survival time for patients with advanced lung cancer
The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).
Henry Ford Cancer Institute First-in-Michigan, Second-in-World to Complete Laser Spinal Ablation
Henry Ford Cancer Institute is the first-in-Michigan and second-in-the-world to complete an innovative cancer treatment known as Spinal Laser Interstitial Thermal Therapy (SLITT), which destroys cancer cells that are adjacent to the spine without the need for open surgery.
Thoracic Oncologist: Vaping is addictive, toxic and young people are more at risk
Since June, almost 200 cases of lung illnesses or injuries linked to vaping have been reported to the federal government. This week, officials stated that there has been one vaping-related death reported. Dr. Eric Bernicker, thoracic oncologist with Houston Methodist, is…
New Drug Combination Shows Promising Activity in Non-Small Cell Lung Cancer Patients
Patients with non-small cell lung cancer (NSCLC) now have more improved treatment options compared to standard of care with the addition of several new agents called immune-checkpoint inhibitors (ICI). Despite these changes, many patients still develop progressive disease after ICI treatment. In a new study published in Clinical Cancer Research, Moffitt Cancer Center researchers describe promising results from an early clinical trial that may offer patients who progress after ICI an additional treatment option.
Boehringer Ingelheim and MD Anderson form unique virtual research and development center to rapidly advance new cancer therapies
Boehringer Ingelheim and MD Anderson have announced a new multi-year partnership to conduct collaborative research, combining the drug-development capabilities of MD Anderson with the pipeline of novel medicines from Boehringer Ingelheim.
Leading Health Organizations Introduce New Award to Advance Lung Cancer Research
The Society of Thoracic Surgeons—along with its charitable arm, The Thoracic Surgery Foundation (TSF)—and the American Lung Association have established a new grant, the Lung Cancer Research Award, designed to support investigators performing impactful lung cancer research.